Abstract
Purposes
The purpose of this study was to retrospectively study embryonal tumors with multilayered rosettes (ETMR), a rare new entity that gathers ETAN-TR (embryonal tumor with abundant neuropil and true rosettes), ependymoblastomas, and medulloepitheliomas, in order to improve their descriptions and try to better define therapeutic modalities.
Methods
Patients with ETMR, ETAN-TR, ependymoblastoma, and medulloepithelioma treated in SFCE centres (Société Française de lutte contre les Cancers et les leucémies de l'Enfant et de l'adolescent) since 2000 were collected. Data were retrieved from clinical charts.
Results
Thirty-eight patients were included in the analysis. Seventeen had an ETAN-TR, 13 had a medulloepithelioma, and 8 had an ETMR. No ependymoblastoma was included. The median age at diagnosis was 31 months (range, 2.8–141 months). The predominant tumor location was supratentorial (66 %); 18.4 % patients had metastatic lesion.
LIN28A expression was positive in 11/11 patients. Amplification of the locus 19q13.42 was positive in 10/12 patients. Thirty patients were treated according to the primitive neuroectodermal tumors of high risk (PNET-HR) protocol. The median time of follow-up was 0.9 years (range 0.1 to 15.3 years). The 1-year event-free survival (EFS) and overall survival (OS) were, respectively, 36 % CI 95 % (23–55) and 45 % CI 95 % (31–64). On multivariate analysis, complete surgical resection, radiotherapy, and high-dose chemotherapy were associated with a better overall survival with a relative risk of, respectively, 7.9 CI 95 % (2.6–23.5) p < 0.0002, 41.8 CI 95 % (9.4–186) p < 0.0001, and 3.5 CI 95 % (1.3–9.5) p = 0.012.
Conclusion
Prognosis of ETMR remains dismal despite multimodal therapy. LIN28A immunostaining and 19q13.42 amplification should be systematically done to secure the diagnosis. Complete surgical resection, radiotherapy, and high-dose chemotherapy are associated with better outcome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ceccom J, Bourdeaut F, Loukh N, Rigau V, Milin S, Takin R, et al. (2014) Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature. Clin Neuropathol 33(1):15–22
Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DTW, et al. (2014) Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128(2):279–289
Paulus W, Kleihues P (2010) Genetic profiling of CNS tumors extends histological classification. Acta Neuropathol 120(2):269–270
Korshunov A, Remke M, Gessi M, Ryzhova M, Hielscher T, Witt H, et al. (2010) Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol 120(2):253–260
Korshunov A, Ryzhova M, Jones DTW, Northcott PA, van Sluis P, Volckmann R, et al. (2012) LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 124(6):875–881
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109
Eberhart CG, Brat DJ, Cohen KJ, Burger PC (2000) Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 3(4):346–352
Gessi M, Giangaspero F, Lauriola L, Gardiman M, Scheithauer BW, Halliday W, et al. (2009) Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 33(2):211–217
Dufour C, Delisle M-B, Geoffray A, Laplanche A, Frappaz D, Icher C, et al. (2014) CT-003. Tandem high-dose chemotherapy with stem cell rescue followed by risk-adapted radiation in children with high-risk cerebral primitive neuroectodermal tumor: results of the prospective sfce-trial pnet hr + 5. Neuro-Oncology 16(suppl 1):i10–i13
Picard D, Miller S, Hawkins CE, Bouffet E, Rogers HA, Chan TSY, et al. (2012) Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol 13(8):838–848
Alexiou GA, Stefanaki K, Vartholomatos G, Sfakianos G, Prodromou N, Moschovi M (2013) Embryonal tumor with abundant neuropil and true rosettes: a systematic literature review and report of 2 new cases. J Child Neurol 28(12):1709–1715
Buccoliero AM, Castiglione F, Rossi Degl’Innocenti D, Franchi A, Paglierani M, Sanzo M, et al. (2010) Embryonal tumor with abundant neuropil and true rosettes: morphological, immunohistochemical, ultrastructural and molecular study of a case showing features of medulloepithelioma and areas of mesenchymal and epithelial differentiation. Neuropathology 30(1):84–91
Lafay-Cousin L, Hader W, Wei XC, Nordal R, Strother D, Hawkins C, et al. (2014) Post-chemotherapy maturation in supratentorial primitive neuroectodermal tumors. Brain Pathol 24(2):166–172
Odagiri K, Omura M, Hata M, Aida N, Niwa T, Goto H, et al. (2014) Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors. Radiat Oncol 9:201
Kim SY, Sung KW, Hah JO, Yoo KH, Koo HH, Kang HJ, et al. (2010) Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor. Korean J Hematol 45(2):120–126
Padovani L, André N, Constine LS, Muracciole X (2012) Neurocognitive function after radiotherapy for paediatric brain tumours. Nat Rev Neurol 8(10):578–588
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Horwitz, M., Dufour, C., Leblond, P. et al. Embryonal tumors with multilayered rosettes in children: the SFCE experience. Childs Nerv Syst 32, 299–305 (2016). https://doi.org/10.1007/s00381-015-2920-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-015-2920-2